Navigation Links
Latest Pharmaceutical Launch Strategies Demonstrate Growing Importance of Thought Leader Engagement at Market Entry
Date:10/25/2011

CHAPEL HILL, N.C., Oct. 25, 2011 /PRNewswire/ -- While some newly-developed bio-pharmaceutical products thrive upon launch, many more struggle in today's crowded, competitive marketplace.  

In order to differentiate the treatment benefits of their new products, companies must think strategically about clinical and scientific thought leaders, targeting and engaging those who often serve as the gatekeepers to a product's acceptance in the medical community.

In fact, according to "Success Factors and Failure Points in Cardiovascular Product Launches," more than 80% of participating bio-pharmaceutical companies in Cardiology have found that engaging thought leaders in the actual protocol designs for late-Phase clinical trials is a highly effective method for building product and treatment momentum.

In addition, participating companies rate Advisory Boards and Clinical Trial Involvement as the most effective strategies for cultivating a successful environment at launch, according to this primary research conducted by Best Practices, LLC.

The study, which examines the product manufacturers in the Cardiology therapeutic area, provides insights to a critical core set of functions and activities during product launch, such as engagement of thought leaders and education of key stakeholders.

Download a complimentary study summary at http://www.best-in-class.com/dr354.htm that includes best practices drawn from extensive primary research with 44 executives and managers from 38 leading pharmaceutical, biotech and medical device companies.

Other key insights include:

  • Thought leader engagement is a critical success factor across all therapeutic areas. However, key relationship tactics score quite differently across Cardiology, Diabetes and the multi-therapeutic area class.
  • Payers and patient advocacy are becoming more important constituents for educating the market. Importantly, Diabetes and Cardiology accord different relative importance to each of these constituents.

The full 182-page report presents launch leaders' perspectives on the current and future risk levels for an array of pitfall factors that can affect a new product launch.  In all, the study contains more than 750 benchmark metrics and 39 executive narratives from leaders in the industry.

For more information on this study and other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies.

The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hologic to Host Special Tomosynthesis Symposium and Feature the Latest in Womens Health Technologies at the Journees Francaises de Radiologie (JFR)
2. Latest Health and Wellness In-Car Technology from Ford to be Showcased Oct. 10-13 in San Diego
3. 2011 Medical Innovation Summit to Showcase Latest Innovations in Cardiovascular Care
4. New York Dermatologist Offers the Latest in Pelleve Wrinkle Reduction Technology
5. Contained Medication System Now Keeping Hospitals Compliant With Latest Legislation
6. Ruby+Associates Completes Latest Mercy Health Systems Design-Build Project
7. Top 5 Ways to Get Insider Track on Healthcare, Pharma & Biotech Discoveries & Latest News
8. Latest Information on Obese Patients with Type 2 Diabetes and LAP-BAND System
9. Latest Releases of Elektas XiO Planning and Focal Contouring Systems Designed to Increase Efficiency in Planning Therapy for Patients with Cancer
10. Enzymatics Reports Latest Growth Figures; Confirms Massachusetts Emerging Role as Leading Bio-manufacturing Center
11. Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)...  International Biophysics Corporation, a global medical device manufacturer based ... 34% revenue growth in 2016 when compared to the previous ... growth was fueled by its AffloVest® sales in ... of its global sales of surgical product lines. ... enter our 25 th year in delivering high-quality, innovative ...
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, ... clinical-stage drug development company focused on tissue protection, ... for RGN-137, GtreeBNT Co., Ltd., received a positive ... 3 clinical trial design for RGN-137 to treat ... healing gel that incorporates Thymosin beta 4 ("Tß4") ...
(Date:2/27/2017)... Leading Countries, Technologies and Companies The global ... CAGR of 8.9% from 2016-2021 and CAGR of 9.2% from 2021-2027. ... from 2016 to 2027. The market is estimated at $816m in ... ... to discover how you can exploit the future business opportunities emerging ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... ... last week. In addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds ... 2014. The company had 800 customers and 2,250 RCEs at the time of ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of Kim ... over nerve agents and the deadly use of chemical weapons. Many questions exist about ... even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a new ... B2B Sellers will now only pay for B.A.N.T. quality sales leads based on the ... said, “Given the new reality that B2B buyers are controlling the sales process via ...
(Date:2/25/2017)... Viejo, CA (PRWEB) , ... February 25, 2017 , ... ... with ProSharpen Color tools from Pixel Film Studios. With ProSharpen Color users have total ... sliders to easily refine their color range. With color spectrum tools users can visually ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of genetic variants implicated ... to eight genes that may explain why susceptibility to one of the disorders could ... study published today in the journal npj Schizophrenia. , “There is a wealth ...
Breaking Medicine News(10 mins):